{"id":57804,"date":"2023-07-26T01:04:57","date_gmt":"2023-07-25T23:04:57","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\/"},"modified":"2023-07-26T01:04:57","modified_gmt":"2023-07-25T23:04:57","slug":"afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\/","title":{"rendered":"Afya Limited to Report Second Quarter and First Half 2023 Financial Results on August 28"},"content":{"rendered":"
\n

NOVA LIMA, Brazil–(BUSINESS WIRE)–Afya Limited, or \u201cAfya\u201d (Nasdaq: AFYA)<\/b> announced today that it will report second-quarter and first half 2023 financial results for the period ended June 30, 2023, following the close of the market on Monday, August 28, 2023 and will host a corresponding conference call and webcast at 05:00 pm EDT.<\/p>\n

<\/a>
<\/a><\/p>\n

\nA live and archived webcast of the call will be available on the Investor Relations section of the Company\u2019s website at https:\/\/ir.afya.com.br\/<\/a>.<\/p>\n

\nTo participate in Afya\u2019s Second Quarter and First Half 2023 conference call, please follow the instructions below:<\/b><\/p>\n

\nWebcast: https:\/\/afya.zoom.us\/j\/98725139496<\/a><\/p>\n

\nDial-in:<\/p>\n

\nBrazil: +55 21 3958 7888 or +55 11 4632 2236 or +55 11 4632 2237 or +55 11 4680 6788 or +55 11 4700 9668.<\/p>\n

\nUnited States: +1 305 224 1968 or +1 309 205 3325 or +1 312 626 6799 or +1 346 248 7799 or +1 360 209 5623 or +1 386 347 5053 or +1 507 473 4847 or +1 564 217 2000 or +1 646 931 3860 or +1 669 444 9171 or +1 669 900 6833 or +1 689 278 1000 or +1 719 359 4580 or +1 929 205 6099 or +1 253 205 0468 or +1 253 215 8782 or +1 301 715 8592.<\/p>\n

\nID for webinar: 987 2513 9496<\/p>\n

\nAbout Afya Limited<\/b><\/p>\n

\nAfya is a leading medical education group in Brazil based on the number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students and physicians to transform their ambitions into rewarding lifelong experiences from the moment they join us as medical students through their medical residency preparation, graduation program, continuing medical education activities and offering digital products to help doctors enhance their healthcare services through their whole career.<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact:<\/b> ir@afya.com.br<\/a>
IR Website:<\/b> ir.afya.com.br<\/a><\/p>\n

\nMedia Contact:<\/b>
C\u00edntia Moraes Marin
\n
cintia.marin@afya.com.br<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NOVA LIMA, Brazil–(BUSINESS WIRE)–Afya Limited, or \u201cAfya\u201d (Nasdaq: AFYA) announced today that it will report second-quarter and first half 2023 financial results for the period ended June 30, 2023, following the close of the market on Monday, August 28, 2023 and will host a corresponding conference call and webcast at 05:00 pm EDT. A live … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-57804","6":"format-standard","7":"category-industry"},"yoast_head":"\nAfya Limited to Report Second Quarter and First Half 2023 Financial Results on August 28 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Afya Limited to Report Second Quarter and First Half 2023 Financial Results on August 28 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NOVA LIMA, Brazil–(BUSINESS WIRE)–Afya Limited, or \u201cAfya\u201d (Nasdaq: AFYA) announced today that it will report second-quarter and first half 2023 financial results for the period ended June 30, 2023, following the close of the market on Monday, August 28, 2023 and will host a corresponding conference call and webcast at 05:00 pm EDT. A live ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-25T23:04:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230725376619\/en\/1850362\/21\/MicrosoftTeams-image_%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Afya Limited to Report Second Quarter and First Half 2023 Financial Results on August 28\",\"datePublished\":\"2023-07-25T23:04:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\\\/\"},\"wordCount\":238,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230725376619\\\/en\\\/1850362\\\/21\\\/MicrosoftTeams-image_%281%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\\\/\",\"name\":\"Afya Limited to Report Second Quarter and First Half 2023 Financial Results on August 28 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230725376619\\\/en\\\/1850362\\\/21\\\/MicrosoftTeams-image_%281%29.jpg\",\"datePublished\":\"2023-07-25T23:04:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230725376619\\\/en\\\/1850362\\\/21\\\/MicrosoftTeams-image_%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230725376619\\\/en\\\/1850362\\\/21\\\/MicrosoftTeams-image_%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Afya Limited to Report Second Quarter and First Half 2023 Financial Results on August 28\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Afya Limited to Report Second Quarter and First Half 2023 Financial Results on August 28 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\/","og_locale":"en_US","og_type":"article","og_title":"Afya Limited to Report Second Quarter and First Half 2023 Financial Results on August 28 - Pharma Trend","og_description":"NOVA LIMA, Brazil–(BUSINESS WIRE)–Afya Limited, or \u201cAfya\u201d (Nasdaq: AFYA) announced today that it will report second-quarter and first half 2023 financial results for the period ended June 30, 2023, following the close of the market on Monday, August 28, 2023 and will host a corresponding conference call and webcast at 05:00 pm EDT. A live ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\/","og_site_name":"Pharma Trend","article_published_time":"2023-07-25T23:04:57+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230725376619\/en\/1850362\/21\/MicrosoftTeams-image_%281%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Afya Limited to Report Second Quarter and First Half 2023 Financial Results on August 28","datePublished":"2023-07-25T23:04:57+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\/"},"wordCount":238,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230725376619\/en\/1850362\/21\/MicrosoftTeams-image_%281%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\/","url":"https:\/\/pharma-trend.com\/en\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\/","name":"Afya Limited to Report Second Quarter and First Half 2023 Financial Results on August 28 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230725376619\/en\/1850362\/21\/MicrosoftTeams-image_%281%29.jpg","datePublished":"2023-07-25T23:04:57+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230725376619\/en\/1850362\/21\/MicrosoftTeams-image_%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230725376619\/en\/1850362\/21\/MicrosoftTeams-image_%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/afya-limited-to-report-second-quarter-and-first-half-2023-financial-results-on-august-28\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Afya Limited to Report Second Quarter and First Half 2023 Financial Results on August 28"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/57804","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=57804"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/57804\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=57804"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=57804"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=57804"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}